Trial · NCT03557307
Adverse events316
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 316
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Influenza like illness | General disorders | Benra 30 mg | 33 | 598 | 34 |
| other | Influenza like illness | General disorders | Asthma Treatment as Per Healthcare Provider Discretion | 0 | 195 | 0 |
| other | Influenza like illness | General disorders | >=50% Any Biologic | 0 | 78 | 0 |
| other | Influenza like illness | General disorders | >=50% Benra | 0 | 69 | 0 |
| other | Nasopharyngitis | Infections and infestations | Benra 30 mg | 64 | 598 | 92 |
| other | Nasopharyngitis | Infections and infestations | Asthma Treatment as Per Healthcare Provider Discretion | 0 | 195 | 0 |
| other | Nasopharyngitis | Infections and infestations | >=50% Any Biologic | 0 | 78 | 0 |
| other | Nasopharyngitis | Infections and infestations | >=50% Benra | 0 | 69 | 0 |
| other | Sinusitis | Infections and infestations | Benra 30 mg | 19 | 598 | 22 |
| other | Sinusitis | Infections and infestations | Asthma Treatment as Per Healthcare Provider Discretion | 0 | 195 | 0 |
| other | Sinusitis | Infections and infestations | >=50% Any Biologic | 0 | 78 | 0 |
| other | Sinusitis | Infections and infestations | >=50% Benra | 0 | 69 | 0 |
| other | Upper respiratory tract infection | Infections and infestations | Benra 30 mg | 25 | 598 | 28 |
| other | Upper respiratory tract infection | Infections and infestations | Asthma Treatment as Per Healthcare Provider Discretion | 0 | 195 | 0 |
| other | Upper respiratory tract infection | Infections and infestations | >=50% Any Biologic | 0 | 78 | 0 |
| other | Upper respiratory tract infection | Infections and infestations | >=50% Benra | 0 | 69 | 0 |
| other | Viral upper respiratory tract infection | Infections and infestations | Benra 30 mg | 28 | 598 | 31 |
| other | Viral upper respiratory tract infection | Infections and infestations | Asthma Treatment as Per Healthcare Provider Discretion | 0 | 195 | 0 |
| other | Viral upper respiratory tract infection | Infections and infestations | >=50% Any Biologic | 0 | 78 | 0 |
| other | Viral upper respiratory tract infection | Infections and infestations | >=50% Benra | 0 | 69 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03557307/events